Akums Drugs & Pharmaceuticals Ltd Share Price (AKUMS)
Check the latest share price of Akums Drugs & Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Akums Drugs & Pharmaceuticals Ltd Stock Performance
Get live Akums Drugs & Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹555Day's Price Range₹578.552 Week's Low
52 Week's High
₹40552-Week Price Range₹1,175.9
| Returns % | |
| 1 Month Return | + 10.1 % |
| 3 Month Return | + 12.7 % |
| 1 Year Return | -28.13 % |
| 3 Year Return | -28.13 % |
| 5 Year Return | -28.13 % |
| Market Stats | |
| Previous Close | ₹569.35 |
| Open | ₹556.60 |
| Volume | 1.11L |
| Upper Circuit | ₹626.25 |
| Lower Circuit | ₹512.45 |
Akums Drugs & Pharmaceuticals Ltd Fundamentals & Key Indicators
Check Akums Drugs & Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹6.24 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Industry PE ratio
57.39
Beta (LTM)
0.32
P/B Ratio
-0.04
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-479.05
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
How to invest in Akums Drugs & Pharmaceuticals Ltd?
Investing in Akums Drugs & Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Akums Drugs & Pharmaceuticals Ltd or AKUMS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Akums Drugs & Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Akums Drugs & Pharmaceuticals Ltd with just a few clicks!
Akums Drugs & Pharmaceuticals Ltd Stock's Interest Amongst Investors
Akums Drugs & Pharmaceuticals Ltd Valuation
Track how Akums Drugs & Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (18.75x)
April 7, 2025
Today (25.46x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (66.86x)
August 19, 2024
Today’s Price to Earnings Ratio: 25.46x
Akums Drugs & Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Akums Drugs & Pharmaceuticals Ltd.
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Akums Drugs & Pharmaceuticals Ltd. Average target price of ₹750
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd price forecast by 3 analysts
Upside of31.05%
High
₹840
Target
₹750.00
Low
₹700
Akums Drugs & Pharmaceuticals Ltd target price ₹750, a slight upside of 31.05% compared to current price of ₹572.3. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Akums Drugs & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Akums Drugs & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Akums Drugs & Pharmaceuticals Ltd, including revenue, profit, loss and more.
Indices Featuring Akums Drugs & Pharmaceuticals Ltd Stock
Check stock indices that include Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 457.26% since last year same period to ₹147.62Cr in the Q4 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 126.48% jump in its net profits since last 3-months.
Read More about Earnings Results
Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Akums Drugs & Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 75.26% | 0.00 | |
| Foreign Institutions | 5.77% | 0.00 | |
| Mutual Funds | 6.11% | 0.00 | |
| Retail Investors | 8.85% | 0.00 | |
| Others | 4.01% | 0.00 |
Akums Drugs & Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Akums Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 | |
| NA | 375.28 | 30.71% | 0.51 | NA | NA |
Akums Drugs & Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Akums Drugs & Pharmaceuticals Ltd.
Akums Reports Decline in Profit Amid Revenue Growth - 26 May, 2025
Akums Drugs and Pharmaceuticals Ltd. reported a 4.3% decline in Q4 FY25 net profit despite a 12.4% revenue increase. The company faces margin pressures but maintains profitability through operational discipline and strategic investments. A €200 million contract for European markets marks a significant step in global expansion.Akums Secures Patent for Nausea Drug in Pregnancy - 05 May, 2025
Akums Drugs & Pharmaceuticals has received a patent for a dual-action nausea drug for pregnant women, combining Doxylamine and Pyridoxine. The formulation, approved by DCGI, aims to provide extended symptom relief and improve dosing convenience for managing nausea and vomiting in pregnancy.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 8.65% to 8.85% in Mar 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 5.54% to 6.11% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, AKUMS stock has moved up by 0.7%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 6.36% to 5.77% in Mar 2025 quarter
About Akums Drugs & Pharmaceuticals Ltd
Revenue: ₹1,055.55Cr as on March 2025 (Q4 FY25)
Net Profit: ₹149.61Cr as on March 2025 (Q4 FY25)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own Akums Drugs & Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Akums Drugs & Pharmaceuticals Ltd.
FAQs
What is Akums Drugs & Pharmaceuticals Ltd share price today?
Akums Drugs & Pharmaceuticals Ltd share price today stands at ₹572.3, Open: ₹556.6, Previous Close: ₹569.35, High: ₹578.5, Low: ₹555, 52 Week High: ₹1175.9, 52 Week Low: ₹405.
What is today's traded volume of Akums Drugs & Pharmaceuticals Ltd?
Today's traded volume of Akums Drugs & Pharmaceuticals Ltd is 1.11L. Which means that 1.11L shares of Akums Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Akums Drugs & Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd is ₹9,007.66 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd’s 52 week high is ₹1175.9 and 52 week low is ₹405. The current share price of Akums Drugs & Pharmaceuticals Ltd is ₹572.3, which is -51.33% down from its 52 week high and 41.31% up from its 52 week low.